Redcare Pharmacy N.V. Stock: price and insider trades · Netherlands

Every trade that managers of Redcare Pharmacy N.V. disclose to AFM is tracked on this page. The company sits in the Health Care sector. 10 insiders have disclosed 15 filings since 18 October 2025.

Open-market activity splits into 8 purchases totalling €128k and 7 sales totalling €1.2M; 8 insiders sit on the buying side and 2 insiders on the selling side. The totals exclude 7 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 8 senior executives. At €773k, the sale published on 2 July 2026 by M.S.R. Kohler is the largest of the period (0.058% of market cap).

The latest purchase is recent: it was published 2 days ago, on 16 October 2026.

For context, the typical company on the same exchange (median of 126 companies) published 7 filings over the same period, against 15 filings here. Looking back to 2016, when coverage begins, insiders filed 39 purchases and 28 sales.

Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by AFM and describes the past, not future prices; it is not investment advice.